Bell's Palsy: A Review.
Awantika Singh, Prasad Deshmukh
https://pubmed.ncbi.nlm.nih.gov/36397921Actively Recruiting
Age: 18Years - 80Years
All Genders
Healthy Volunteers
ID06742580
The Relationship Between Idiopathic Acute Peripheral Facial Paralysis and Homocysteine Level in Adult Patients
Led by Murat Akın · Updated on 2024-12-19
80
Participants Needed
3
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Bell's palsy, also called acute facial palsy of unknown cause, is a common nerve condition that causes sudden weakness or paralysis on one side of the face. It often comes with symptoms like pain behind the ear, taste changes, altered facial sensation, and sensitivity to sound. This research aims to explore the relationship between blood homocysteine levels—a substance linked to blood clotting disorders—and idiopathic acute peripheral facial paralysis, as no previous studies have investigated this connection. The study observes two groups: patients who have recently developed idiopathic facial paralysis and healthy individuals without known health issues. Blood homocysteine levels will be measured and compared between these groups. This observational study will follow participants to measure homocysteine over a period of up to 24 weeks. During the study, participants will be monitored through blood tests to assess homocysteine levels. Researchers will evaluate these results to understand if higher homocysteine is related to facial paralysis. The study includes adults aged 18 to 80 years and involves healthy volunteers as a control group. The total participation duration covers up to 24 weeks, with ongoing monitoring of blood test results.
CONDITIONS
Brief Title
The Relationship Between Idiopathic Acute Peripheral Facial Paralysis and Homocysteine Level in Adult Patients
Who Can Participate
Age: 18Years - 80Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- Patients admitted with acute facial paralysis
You will not qualify if you...
- Facial and ear trauma or tumor
- İatrogenic
- Cholesteatoma
- Facial paralysis due to central nervous system diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Diagnostic Evaluation
Duration - Up to 24 weeks
Participants undergo blood tests to measure homocysteine levels and assessments related to idiopathic acute peripheral facial paralysis.
1 to 2 visits depending on group assignment
Trial Site Locations
Total: 3 locations
1
Afyonkarahisar Health Sciences University
Afyonkarahisar, Turkey (Türkiye)
Active, Not Recruiting
2
Afyonkarahisar Health Sciences University
Afyonkarahisar, Turkey (Türkiye)
Actively Recruiting
3
Afyonkarahisar Health Sciences University
Afyonkarahisar, Turkey (Türkiye)
Actively Recruiting
Loading map...
Research Team
M
MURAT AKIN, ASSISTANT DOCTOR
O
Orhan Kemal KAHVECİ, PROFESSOR
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
The relationship between serum homocysteine levels and sudden sensorineural hearing loss: a meta-analysis.
Xun Niu, Yuzhang Chen, Yi Zhong...
https://pubmed.ncbi.nlm.nih.gov/36658368Bell's palsy: aetiology, clinical features and multidisciplinary care.
Timothy J Eviston, Glen R Croxson, Peter G E Kennedy...
https://pubmed.ncbi.nlm.nih.gov/25857657